Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · SI-BONE, Inc. (SIBN)

SI-BONE Q3 revenue rises 14.5% to $55.7 million; net loss narrows; guidance reaffirmed

Positive Impact 3 of 5 earnings Written later

SI-BONE reported third-quarter 2026 results for the quarter ended September 30, 2026. Revenue rose 14.5% to $55.7 million and the net loss narrowed to $3.6 million, while the company reaffirmed its 2026 revenue guidance of $231 million to $233 million and lowered its operating expense growth expectation to 10.5% from 12.0%.

Key points

  • Worldwide revenue was $55.7 million, up 14.5% from $48.7 million a year earlier; U.S. revenue was $52.8 million, up 13.9%.
  • Net loss was $3.6 million, or $0.08 per diluted share, compared with $4.6 million, or $0.11 per share, in the prior-year quarter.
  • 2026 revenue guidance of $231 million to $233 million and gross margin of about 79.0% were reaffirmed.
  • Expected 2026 operating expense growth was reduced to about 10.5% from about 12.0% at the revenue midpoint.

The filing

CompanySI-BONE, Inc. (SIBN)
Form8-K, current report
Filed with the SECNov 2, 2026, 4:10 PM ET
Accession number0001459839-26-000084

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.